Dr. Miele Cosmed Group S.A.

WSE:DMG Stock Report

Market Cap: zł400.9m

Dr. Miele Cosmed Group Balance Sheet Health

Financial Health criteria checks 6/6

Dr. Miele Cosmed Group has a total shareholder equity of PLN255.4M and total debt of PLN55.6M, which brings its debt-to-equity ratio to 21.8%. Its total assets and total liabilities are PLN414.2M and PLN158.9M respectively. Dr. Miele Cosmed Group's EBIT is PLN49.8M making its interest coverage ratio 9.8. It has cash and short-term investments of PLN15.6M.

Key information

21.8%

Debt to equity ratio

zł55.56m

Debt

Interest coverage ratio9.8x
Cashzł15.55m
Equityzł255.39m
Total liabilitieszł158.86m
Total assetszł414.25m

Recent financial health updates

Recent updates

Dr. Miele Cosmed Group S.A. (WSE:DMG) Soars 33% But It's A Story Of Risk Vs Reward

Sep 22
Dr. Miele Cosmed Group S.A. (WSE:DMG) Soars 33% But It's A Story Of Risk Vs Reward

Dr. Miele Cosmed Group S.A.'s (WSE:DMG) Subdued P/S Might Signal An Opportunity

Jul 24
Dr. Miele Cosmed Group S.A.'s (WSE:DMG) Subdued P/S Might Signal An Opportunity

Global Cosmed S.A.'s (WSE:GLC) 32% Price Boost Is Out Of Tune With Earnings

Mar 05
Global Cosmed S.A.'s (WSE:GLC) 32% Price Boost Is Out Of Tune With Earnings

Global Cosmed (WSE:GLC) Might Have The Makings Of A Multi-Bagger

Nov 09
Global Cosmed (WSE:GLC) Might Have The Makings Of A Multi-Bagger

Returns On Capital Are Showing Encouraging Signs At Global Cosmed (WSE:GLC)

Jul 25
Returns On Capital Are Showing Encouraging Signs At Global Cosmed (WSE:GLC)

Global Cosmed (WSE:GLC) Shareholders Will Want The ROCE Trajectory To Continue

Jan 05
Global Cosmed (WSE:GLC) Shareholders Will Want The ROCE Trajectory To Continue

Returns Are Gaining Momentum At Global Cosmed (WSE:GLC)

Jan 05
Returns Are Gaining Momentum At Global Cosmed (WSE:GLC)

With EPS Growth And More, Global Cosmed (WSE:GLC) Is Interesting

Oct 07
With EPS Growth And More, Global Cosmed (WSE:GLC) Is Interesting

Global Cosmed S.A.'s (WSE:GLC) 27% Jump Shows Its Popularity With Investors

Sep 06
Global Cosmed S.A.'s (WSE:GLC) 27% Jump Shows Its Popularity With Investors

Is Global Cosmed (WSE:GLC) Using Too Much Debt?

Sep 02
Is Global Cosmed (WSE:GLC) Using Too Much Debt?

Slowing Rates Of Return At Global Cosmed (WSE:GLC) Leave Little Room For Excitement

May 17
Slowing Rates Of Return At Global Cosmed (WSE:GLC) Leave Little Room For Excitement

Global Cosmed (WSE:GLC) Seems To Use Debt Rather Sparingly

Mar 16
Global Cosmed (WSE:GLC) Seems To Use Debt Rather Sparingly

Introducing Global Cosmed (WSE:GLC), The Stock That Soared 586% In The Last Year

Feb 22
Introducing Global Cosmed (WSE:GLC), The Stock That Soared 586% In The Last Year

Declining Stock and Decent Financials: Is The Market Wrong About Global Cosmed S.A. (WSE:GLC)?

Feb 02
Declining Stock and Decent Financials: Is The Market Wrong About Global Cosmed S.A. (WSE:GLC)?

The Trends At Global Cosmed (WSE:GLC) That You Should Know About

Jan 12
The Trends At Global Cosmed (WSE:GLC) That You Should Know About

Do Institutions Own Global Cosmed S.A. (WSE:GLC) Shares?

Dec 21
Do Institutions Own Global Cosmed S.A. (WSE:GLC) Shares?

Global Cosmed (WSE:GLC) Could Easily Take On More Debt

Nov 23
Global Cosmed (WSE:GLC) Could Easily Take On More Debt

Financial Position Analysis

Short Term Liabilities: DMG's short term assets (PLN141.9M) exceed its short term liabilities (PLN132.7M).

Long Term Liabilities: DMG's short term assets (PLN141.9M) exceed its long term liabilities (PLN26.1M).


Debt to Equity History and Analysis

Debt Level: DMG's net debt to equity ratio (15.7%) is considered satisfactory.

Reducing Debt: DMG's debt to equity ratio has reduced from 35.1% to 21.8% over the past 5 years.

Debt Coverage: DMG's debt is well covered by operating cash flow (68.4%).

Interest Coverage: DMG's interest payments on its debt are well covered by EBIT (9.8x coverage).


Balance Sheet


Discover healthy companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 10:08
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Dr. Miele Cosmed Group S.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution